Care, mapped.

Found a doctor? Keep checking

Check facts / Read the evidence

Ask whether the study was in people.

Read what studies in people have found, and where they still leave questions.

Picture the moment

You find a healing claim with a study attached. Before treating it as an answer, ask who or what was studied.

Begin with what the substance is

BPC-157 is a peptide made in a lab: a short chain made from protein building blocks. A

Its makers copied part of a protein that researchers said they found in fluid inside the human stomach.

Most healing research on BPC-157 has involved animals, especially rats. A

An animal result does not establish that the same treatment works in people.

The human studies leave major gaps

As of September 28, 2026, the Food and Drug Administration (FDA) found five human studies; around 80 people received BPC-157 across them. A

Two studies used a comparison group; neither appeared as a full published paper.

A comparison group helps researchers ask whether a change was due to the treatment. A report without that comparison cannot answer the same question.

The knee-pain report

The report looked back at 17 patients’ records and had no comparison group. B

It cannot show that BPC-157 caused the reported improvement.

The bowel-disease study

For ulcerative colitis, a bowel disease, FDA reviewers found the study too limited to establish that BPC-157 worked. A

That is a limit in the evidence, rather than proof that it cannot work.

A trial plan is not a trial result

As of September 28, 2026, a trial for muscle strains in China was recruiting and had no posted results. C

Look for actual results when a page points to a trial listing. A listing alone describes a plan or its progress.

Check approval and pharmacy rules

As of September 28, 2026, there was no FDA-approved BPC-157 medicine for any US use. A

The FDA also reported no approval for a medicine containing it in any country, as of September 28, 2026.

In compounding, a doctor or pharmacist makes a medicine to order.

As of September 26, 2026, compounded medicines had no FDA approval. D

FDA rules checked September 26, 2026, do not allow regular compounding pharmacies to make BPC-157 medicines from raw ingredients. D

Ask the person offering treatment: “What medicine would you give me? Who would make it? Which law allows that person or pharmacy to use this ingredient? Please show me that rule.”

Continue the checkCheck what the offer leaves outLook beyond a purity figure and reassuring labels.

Notes behind this page

  1. FDA review of the human and animal evidence (PDF)

    It also records the approval search and the assessment of the bowel study.

  2. Knee-pain study listed by the National Library of Medicine

    Check how the researchers chose the patients and whether they used a comparison group, as well as what happened to the patients.

  3. ClinicalTrials.gov list of studies

    These records describe study plans and progress. Ask the health professional for any published results; a planned study does not show whether a treatment works.

  4. FDA rules on which raw ingredients pharmacies may use

    Look for the rules on ingredients. Ask the health professional to show which rule they believe the proposed medicine meets.